OCUMENSION-B(01477) granted stock options and rewards.

OCUMENSION-B (01477) announced that the board of directors believes it is necessary to implement incentive measures to support the strategic growth goals of the group and maintain a competitive advantage in talent recruitment and retention. In recognition of the long-term commitment and valuable contributions made by grant recipients to achieve the group's research and development (R&D) and commercial milestones, the board of directors decided on May 12, 2026 to grant 7.9321 million stock options involving 7.9321 million shares of stock to 498 grant recipients (including Dr. Hu Zhaopeng, an executive director of the company, and one senior management member) under the 2021 stock option plan, and to grant 7.9321 million stock-based rewards involving 7.9321 million shares of stock to 498 grant recipients (including Dr. Hu and one senior management member) under the 2021 share award plan, representing approximately 0.97% of the total issued and outstanding shares (excluding treasury shares) of the company as of the date of the grant.